Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Schizophrenia

  Free Subscription


Articles published in Mol Psychiatry

Retrieve available abstracts of 86 articles:
HTML format
Text format



Single Articles


    March 2018
  1. CHOUINARD VA, Henderson DC, Dalla Man C, Valeri L, et al
    Impaired insulin signaling in unaffected siblings and patients with first-episode psychosis.
    Mol Psychiatry. 2018 Mar 9. pii: 10.1038/s41380-018-0045.
    PubMed     Text format     Abstract available


  2. OSIMO EF, Beck K, Reis Marques T, Howes OD, et al
    Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measures.
    Mol Psychiatry. 2018 Mar 6. pii: 10.1038/s41380-018-0041.
    PubMed     Text format     Abstract available


  3. SULLIVAN CR, Koene RH, Hasselfeld K, O'Donovan SM, et al
    Neuron-specific deficits of bioenergetic processes in the dorsolateral prefrontal cortex in schizophrenia.
    Mol Psychiatry. 2018 Mar 1. pii: 10.1038/s41380-018-0035.
    PubMed     Text format     Abstract available


    February 2018
  4. KIM DD, Barr AM, Honer WG, Procyshyn RM, et al
    Exercise-induced hippocampal neurogenesis: 5-HT3 receptor antagonism by antipsychotics as a potential limiting factor in Schizophrenia.
    Mol Psychiatry. 2018 Feb 8. pii: 10.1038/s41380-018-0022.
    PubMed     Text format    


    January 2018
  5. LIEBERMAN JA, Girgis RR, Brucato G, Moore H, et al
    Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention.
    Mol Psychiatry. 2018 Jan 9. pii: mp2017249. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  6. DE VRIJ FM, Bouwkamp CG, Gunhanlar N, Shpak G, et al
    Candidate CSPG4 mutations and induced pluripotent stem cell modeling implicate oligodendrocyte progenitor cell dysfunction in familial schizophrenia.
    Mol Psychiatry. 2018 Jan 4. pii: 10.1038/s41380-017-0004.
    PubMed     Text format     Abstract available


    November 2017
  7. STEULLET P, Cabungcal JH, Bukhari SA, Ardelt MI, et al
    The thalamic reticular nucleus in schizophrenia and bipolar disorder: role of parvalbumin-expressing neuron networks and oxidative stress.
    Mol Psychiatry. 2017 Nov 28. pii: mp2017230. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  8. CHENG CM, Chang WH, Chen MH, Tsai CF, et al
    Co-aggregation of major psychiatric disorders in individuals with first-degree relatives with schizophrenia: a nationwide population-based study.
    Mol Psychiatry. 2017 Nov 7. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  9. ENWRIGHT III JF, Huo Z, Arion D, Corradi JP, et al
    Transcriptome alterations of prefrontal cortical parvalbumin neurons in schizophrenia.
    Mol Psychiatry. 2017 Nov 7. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  10. KENDLER KS
    The genealogy of major depression: symptoms and signs of melancholia from 1880 to 1900.
    Mol Psychiatry. 2017;22:1539-1553.
    PubMed     Text format     Abstract available


    October 2017
  11. KELLY S, Jahanshad N, Zalesky A, Kochunov P, et al
    Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group.
    Mol Psychiatry. 2017 Oct 17. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  12. GREENE C, Kealy J, Humphries MM, Gong Y, et al
    Dose-dependent expression of claudin-5 is a modifying factor in schizophrenia.
    Mol Psychiatry. 2017 Oct 10. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  13. LEGGE SE, Hamshere ML, Ripke S, Pardinas AF, et al
    Genome-wide common and rare variant analysis provides novel insights into clozapine-associated neutropenia.
    Mol Psychiatry. 2017;22:1502-1508.
    PubMed     Text format     Abstract available


    September 2017
  14. ZHOU Y, Dong F, Lanz TA, Reinhart V, et al
    Interactome analysis reveals ZNF804A, a schizophrenia risk gene, as a novel component of protein translational machinery critical for embryonic neurodevelopment.
    Mol Psychiatry. 2017 Sep 19. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  15. SOLIMAN MA, Aboharb F, Zeltner N, Studer L, et al
    Pluripotent stem cells in neuropsychiatric disorders.
    Mol Psychiatry. 2017;22:1241-1249.
    PubMed     Text format     Abstract available


    August 2017
  16. ALACHKAR A, Wang L, Yoshimura R, Hamzeh AR, et al
    Prenatal one-carbon metabolism dysregulation programs schizophrenia-like deficits.
    Mol Psychiatry. 2017 Aug 15. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  17. GUR RE, Bassett AS, McDonald-McGinn DM, Bearden CE, et al
    A neurogenetic model for the study of schizophrenia spectrum disorders: the International 22q11.2 Deletion Syndrome Brain Behavior Consortium.
    Mol Psychiatry. 2017 Aug 1. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  18. NIMGAONKAR VL, Prasad KM, Chowdari KV, Severance EG, et al
    The complement system: a gateway to gene-environment interactions in schizophrenia pathogenesis.
    Mol Psychiatry. 2017 Aug 1. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


    July 2017
  19. WEINSTEIN JJ, van de Giessen E, Rosengard RJ, Xu X, et al
    PET imaging of dopamine-D2 receptor internalization in schizophrenia.
    Mol Psychiatry. 2017 Jul 25. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  20. BENAMER N, Marti F, Lujan R, Hepp R, et al
    GluD1, linked to schizophrenia, controls the burst firing of dopamine neurons.
    Mol Psychiatry. 2017 Jul 11. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  21. RAO AR, Yourshaw M, Christensen B, Nelson SF, et al
    Rare deleterious mutations are associated with disease in bipolar disorder families.
    Mol Psychiatry. 2017;22:1009-1014.
    PubMed     Text format     Abstract available


    June 2017
  22. TENG S, Thomson PA, McCarthy S, Kramer M, et al
    Rare disruptive variants in the DISC1 Interactome and Regulome: association with cognitive ability and schizophrenia.
    Mol Psychiatry. 2017 Jun 20. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


    May 2017
  23. KIM Y, Giusti-Rodriguez P, Crowley JJ, Bryois J, et al
    Comparative genomic evidence for the involvement of schizophrenia risk genes in antipsychotic effects.
    Mol Psychiatry. 2017 May 30. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  24. WEINSTEIN JJ, van de Giessen E, Rosengard RJ, Xu X, et al
    PET imaging of dopamine-D2 receptor internalization in schizophrenia.
    Mol Psychiatry. 2017 May 16. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  25. MOBERGET T, Doan NT, Alnaes D, Kaufmann T, et al
    Cerebellar volume and cerebellocerebral structural covariance in schizophrenia: a multisite mega-analysis of 983 patients and 1349 healthy controls.
    Mol Psychiatry. 2017 May 16. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  26. BIRNBAUM R, Jaffe AE, Chen Q, Shin JH, et al
    Investigating the neuroimmunogenic architecture of schizophrenia.
    Mol Psychiatry. 2017 May 9. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  27. TAO R, Davis KN, Li C, Shin JH, et al
    GAD1 alternative transcripts and DNA methylation in human prefrontal cortex and hippocampus in brain development, schizophrenia.
    Mol Psychiatry. 2017 May 9. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  28. DEMICHELE-SWEET MAA, Weamer EA, Klei L, Vrana DT, et al
    Genetic risk for schizophrenia and psychosis in Alzheimer disease.
    Mol Psychiatry. 2017 May 2. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


    April 2017
  29. DUNCAN LE, Ratanatharathorn A, Aiello AE, Almli LM, et al
    Largest GWAS of PTSD (N=20 070) yields genetic overlap with schizophrenia and sex differences in heritability.
    Mol Psychiatry. 2017 Apr 25. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  30. HADAR R, Bikovski L, Soto-Montenegro ML, Schimke J, et al
    Early neuromodulation prevents the development of brain and behavioral abnormalities in a rodent model of schizophrenia.
    Mol Psychiatry. 2017 Apr 4. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


    March 2017
  31. NOTTER T, Meyer U
    Microglia and schizophrenia: where next?
    Mol Psychiatry. 2017 Mar 28. doi: 10.1038/mp.2017.
    PubMed     Text format    


  32. PARKER KL, Kim YC, Kelley RM, Nessler AJ, et al
    Delta-frequency stimulation of cerebellar projections can compensate for schizophrenia-related medial frontal dysfunction.
    Mol Psychiatry. 2017 Mar 28. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  33. LYALL AE, Pasternak O, Robinson DG, Newell D, et al
    Greater extracellular free-water in first-episode psychosis predicts better neurocognitive functioning.
    Mol Psychiatry. 2017 Mar 28. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  34. DEVOR A, Andreassen OA, Wang Y, Maki-Marttunen T, et al
    Genetic evidence for role of integration of fast and slow neurotransmission in schizophrenia.
    Mol Psychiatry. 2017 Mar 28. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  35. STEULLET P, Cabungcal JH, Coyle J, Didriksen M, et al
    Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia.
    Mol Psychiatry. 2017 Mar 21. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  36. CHANG H, Xiao X, Li M
    The schizophrenia risk gene ZNF804A: clinical associations, biological mechanisms and neuronal functions.
    Mol Psychiatry. 2017 Mar 14. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  37. PAGE SC, Hamersky GR, Gallo RA, Rannals MD, et al
    The schizophrenia- and autism-associated gene, transcription factor 4 regulates the columnar distribution of layer 2/3 prefrontal pyramidal neurons in an activity-dependent manner.
    Mol Psychiatry. 2017 Mar 14. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  38. ROFFMAN JL, Petruzzi LJ, Tanner AS, Brown HE, et al
    Biochemical, physiological and clinical effects of l-methylfolate in schizophrenia: a randomized controlled trial.
    Mol Psychiatry. 2017 Mar 14. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  39. ORHAN F, Fatouros-Bergman H, Goiny M, Malmqvist A, et al
    CSF GABA is reduced in first-episode psychosis and associates to symptom severity.
    Mol Psychiatry. 2017 Mar 14. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


  40. WESSELING H, Xu B, Want EJ, Holmes E, et al
    System-based proteomic and metabonomic analysis of the Df(16)A+/- mouse identifies potential miR-185 targets and molecular pathway alterations.
    Mol Psychiatry. 2017;22:384-395.
    PubMed     Text format     Abstract available


    February 2017
  41. LEE PH, Baker JT, Holmes AJ, Jahanshad N, et al
    Partitioning heritability analysis reveals a shared genetic basis of brain anatomy and schizophrenia.
    Mol Psychiatry. 2017 Feb 21. doi: 10.1038/mp.2017.
    PubMed     Text format    


  42. COLLSTE K, Plaven-Sigray P, Fatouros-Bergman H, Victorsson P, et al
    Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [11C]PBR28.
    Mol Psychiatry. 2017 Feb 14. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


  43. LEE M, Sehatpour P, Hoptman MJ, Lakatos P, et al
    Neural mechanisms of mismatch negativity dysfunction in schizophrenia.
    Mol Psychiatry. 2017 Feb 7. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


    January 2017
  44. MITCHELL AC, Javidfar B, Pothula V, Ibi D, et al
    MEF2C transcription factor is associated with the genetic and epigenetic risk architecture of schizophrenia and improves cognition in mice.
    Mol Psychiatry. 2017 Jan 24. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


  45. ROALF DR, Nanga RP, Rupert PE, Hariharan H, et al
    Glutamate imaging (GluCEST) reveals lower brain GluCEST contrast in patients on the psychosis spectrum.
    Mol Psychiatry. 2017 Jan 24. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


  46. VAUCHER J, Keating BJ, Lasserre AM, Gan W, et al
    Cannabis use and risk of schizophrenia: a Mendelian randomization study.
    Mol Psychiatry. 2017 Jan 24. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


  47. NOTTER T, Coughlin JM, Gschwind T, Weber-Stadlbauer U, et al
    Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia.
    Mol Psychiatry. 2017 Jan 17. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


  48. QIN XY, Wu HT, Cao C, Loh YP, et al
    A meta-analysis of peripheral blood nerve growth factor levels in patients with schizophrenia.
    Mol Psychiatry. 2017 Jan 10. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


  49. ST POURCAIN B, Robinson EB, Anttila V, Sullivan BB, et al
    ASD and schizophrenia show distinct developmental profiles in common genetic overlap with population-based social communication difficulties.
    Mol Psychiatry. 2017 Jan 3. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


  50. WEBER-STADLBAUER U, Richetto J, Labouesse MA, Bohacek J, et al
    Transgenerational transmission and modification of pathological traits induced by prenatal immune activation.
    Mol Psychiatry. 2017;22:102-112.
    PubMed     Text format     Abstract available


    December 2016
  51. CLIFTON NE, Pocklington AJ, Scholz B, Rees E, et al
    Schizophrenia copy number variants and associative learning.
    Mol Psychiatry. 2016 Dec 13. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


  52. YU H, Yan H, Li J, Li Z, et al
    Common variants on 2p16.1, 6p22.1 and 10q24.32 are associated with schizophrenia in Han Chinese population.
    Mol Psychiatry. 2016 Dec 6. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


    November 2016
  53. BADER V, Trossbach SV, Prikulis I, Godsave SF, et al
    Misassembly of non-mutant full-length Disrupted-in-Schizophrenia 1 protein is induced by dopamine in vitro and in vivo.
    Mol Psychiatry. 2016;21:1487.
    PubMed     Text format    


  54. SCARR E, Udawela M, Thomas EA, Dean B, et al
    Changed gene expression in subjects with schizophrenia and low cortical muscarinic M1 receptors predicts disrupted upstream pathways interacting with that receptor.
    Mol Psychiatry. 2016 Nov 1. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


    October 2016
  55. DELEVICH K, Abi-Dargham A, Hall J, Sawa A, et al
    Studying schizophrenia in the post-genomic era: perspectives from the 2016 summer Banbury Workshop at Cold Spring Harbor Laboratory.
    Mol Psychiatry. 2016 Oct 25. doi: 10.1038/mp.2016.
    PubMed     Text format    


  56. XU J, Hartley BJ, Kurup P, Phillips A, et al
    Inhibition of STEP61 ameliorates deficits in mouse and hiPSC-based schizophrenia models.
    Mol Psychiatry. 2016 Oct 18. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


  57. LEE PH, Baker JT, Holmes AJ, Jahanshad N, et al
    Partitioning heritability analysis reveals a shared genetic basis of brain anatomy and schizophrenia.
    Mol Psychiatry. 2016 Oct 11. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


  58. HASAN A, Wobrock T, Guse B, Langguth B, et al
    Structural brain changes are associated with response of negative symptoms to prefrontal repetitive transcranial magnetic stimulation in patients with schizophrenia.
    Mol Psychiatry. 2016 Oct 11. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


  59. HOLMES SE, Hinz R, Drake RJ, Gregory CJ, et al
    In vivo imaging of brain microglial activity in antipsychotic-free and medicated schizophrenia: a [11C](R)-PK11195 positron emission tomography study.
    Mol Psychiatry. 2016 Oct 4. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


    September 2016
  60. STEDEHOUDER J, Kushner SA
    Myelination of parvalbumin interneurons: a parsimonious locus of pathophysiological convergence in schizophrenia.
    Mol Psychiatry. 2016 Sep 20. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


  61. NIWA M, Cash-Padgett T, Kubo KI, Saito A, et al
    DISC1 a key molecular lead in psychiatry and neurodevelopment: No-More Disrupted-in-Schizophrenia 1.
    Mol Psychiatry. 2016 Sep 6. doi: 10.1038/mp.2016.
    PubMed     Text format    


    August 2016
  62. DONEGAN JJ, Tyson JA, Branch SY, Beckstead MJ, et al
    Stem cell-derived interneuron transplants as a treatment for schizophrenia: preclinical validation in a rodent model.
    Mol Psychiatry. 2016 Aug 2. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


    July 2016
  63. KIM MJ, Biag J, Fass DM, Lewis MC, et al
    Functional analysis of rare variants found in schizophrenia implicates a critical role for GIT1-PAK3 signaling in neuroplasticity.
    Mol Psychiatry. 2016 Jul 26. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


    June 2016
  64. TREPANIER MO, Hopperton KE, Mizrahi R, Mechawar N, et al
    Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review.
    Mol Psychiatry. 2016 Jun 7. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


    May 2016
  65. KUSHIMA I, Aleksic B, Nakatochi M, Shimamura T, et al
    High-resolution copy number variation analysis of schizophrenia in Japan.
    Mol Psychiatry. 2016 May 31. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


  66. JENKINS AK, Paterson C, Wang Y, Hyde TM, et al
    Neurexin 1 (NRXN1) splice isoform expression during human neocortical development and aging.
    Mol Psychiatry. 2016;21:701-6.
    PubMed     Text format     Abstract available


    April 2016
  67. KEBIR O, Chaumette B, Rivollier F, Miozzo F, et al
    Methylomic changes during conversion to psychosis.
    Mol Psychiatry. 2016 Apr 26. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


    March 2016
  68. HOMANN OR, Misura K, Lamas E, Sandrock RW, et al
    Whole-genome sequencing in multiplex families with psychoses reveals mutations in the SHANK2 and SMARCA1 genes segregating with illness.
    Mol Psychiatry. 2016 Mar 22. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


    February 2016
  69. HO NF, Iglesias JE, Sum MY, Kuswanto CN, et al
    Progression from selective to general involvement of hippocampal subfields in schizophrenia.
    Mol Psychiatry. 2016 Feb 23. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


  70. GOLDSMITH DR, Rapaport MH, Miller BJ
    A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.
    Mol Psychiatry. 2016 Feb 23. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


  71. CARR GV, Chen J, Yang F, Ren M, et al
    KCNH2-3.1 expression impairs cognition and alters neuronal function in a model of molecular pathology associated with schizophrenia.
    Mol Psychiatry. 2016 Feb 9. doi: 10.1038/mp.2015.
    PubMed     Text format     Abstract available


  72. MCCLATCHY DB, Savas JN, Martinez-Bartolome S, Park SK, et al
    Global quantitative analysis of phosphorylation underlying phencyclidine signaling and sensorimotor gating in the prefrontal cortex.
    Mol Psychiatry. 2016;21:205-15.
    PubMed     Text format     Abstract available


  73. LI J, Cai T, Jiang Y, Chen H, et al
    Genes with de novo mutations are shared by four neuropsychiatric disorders discovered from NPdenovo database.
    Mol Psychiatry. 2016;21:290-7.
    PubMed     Text format     Abstract available


  74. LU C, Chen Q, Zhou T, Bozic D, et al
    Micro-electrode array recordings reveal reductions in both excitation and inhibition in cultured cortical neuron networks lacking Shank3.
    Mol Psychiatry. 2016;21:159-68.
    PubMed     Text format     Abstract available


  75. ROWLAND LM, Krause BW, Wijtenburg SA, McMahon RP, et al
    Medial frontal GABA is lower in older schizophrenia: a MEGA-PRESS with macromolecule suppression study.
    Mol Psychiatry. 2016;21:198-204.
    PubMed     Text format     Abstract available


  76. KENDLER KS
    The transformation of American psychiatric nosology at the dawn of the twentieth century.
    Mol Psychiatry. 2016;21:152-8.
    PubMed     Text format     Abstract available


    January 2016
  77. OKADA N, Fukunaga M, Yamashita F, Koshiyama D, et al
    Abnormal asymmetries in subcortical brain volume in schizophrenia.
    Mol Psychiatry. 2016 Jan 19. doi: 10.1038/mp.2015.
    PubMed     Text format     Abstract available


  78. TROSSBACH SV, Bader V, Hecher L, Pum ME, et al
    Misassembly of full-length Disrupted-in-Schizophrenia 1 protein is linked to altered dopamine homeostasis and behavioral deficits.
    Mol Psychiatry. 2016 Jan 12. doi: 10.1038/mp.2015.
    PubMed     Text format     Abstract available


  79. GUAN L, Wang Q, Wang L, Wu B, et al
    Common variants on 17q25 and gene-gene interactions conferring risk of schizophrenia in Han Chinese population and regulating gene expressions in human brain.
    Mol Psychiatry. 2016 Jan 5. doi: 10.1038/mp.2015.
    PubMed     Text format     Abstract available


  80. GREEN EK, Rees E, Walters JT, Smith KG, et al
    Copy number variation in bipolar disorder.
    Mol Psychiatry. 2016;21:89-93.
    PubMed     Text format     Abstract available


    December 2015
  81. SELLGREN CM, Kegel ME, Bergen SE, Ekman CJ, et al
    A genome-wide association study of kynurenic acid in cerebrospinal fluid: implications for psychosis and cognitive impairment in bipolar disorder.
    Mol Psychiatry. 2015 Dec 15. doi: 10.1038/mp.2015.
    PubMed     Text format     Abstract available


  82. TANSEY KE, Rees E, Linden DE, Ripke S, et al
    Common alleles contribute to schizophrenia in CNV carriers.
    Mol Psychiatry. 2015 Dec 8. doi: 10.1038/mp.2015.
    PubMed     Text format    


    June 2015
  83. KULKARNI J, Gavrilidis E, Wang W, Worsley R, et al
    Estradiol for treatment-resistant schizophrenia: a large-scale randomized-controlled trial in women of child-bearing age.
    Mol Psychiatry. 2015;20:695-702.
    PubMed     Text format     Abstract available


    March 2015
  84. BRENNAND K, Savas JN, Kim Y, Tran N, et al
    Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia.
    Mol Psychiatry. 2015;20:361-8.
    PubMed     Text format     Abstract available


    February 2015
  85. FRANK J, Lang M, Witt SH, Strohmaier J, et al
    Identification of increased genetic risk scores for schizophrenia in treatment-resistant patients.
    Mol Psychiatry. 2015;20:150-1.
    PubMed     Text format    


  86. ANDREASSEN OA, Harbo HF, Wang Y, Thompson WK, et al
    Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci.
    Mol Psychiatry. 2015;20:207-14.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: